ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Artificial Intelligence Revolution in Transcriptomics: From Single Cells to Spatial Atlases.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Deep Learning-Assisted Prioritization of Candidate Drug Targets in Tumors Using Spatial Multi-Omics.Biology · 2026Review
- Identification of ATF3 as a Potential Key Biomarker for Hypertensive Nephropathy via Single-Cell Transcriptome Sequencing.Inflammation · 2026Article
- Extracellular vesicles in the heart: mediators of intercellular communication in health and disease in vitro.Cell communication and signaling : CCS · 2026Review
- Artificial Intelligence Revolution in Transcriptomics: From Single Cells to Spatial Atlases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.Frontiers in pharmacology · 2026Review
- Transcriptomics and AI-driven approaches to the diagnosis and treatment of rheumatoid arthritis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) have revolutionized the study of cellular heterogeneity and tissue organization. However, the increasing scale and complexity of these data demand more powerful and integrative computational strategies. Although conventional statistical and machine learning methods remain effective in specific contexts, they face limitations in scalability, multimodal integration, and generalization. In response, artificial intelligence (AI) has emerged as a transformative force, enabling new modes of analysis and interpretation. In this review, we survey AI applications across the transcriptomic analysis workflow-from initial preprocessing through key downstream analyses such as trajectory inference, gene regulatory network reconstruction, and spatial domain detection. For each analytical task, we trace the developmental trajectory and evolving trends of AI models, summarize their advantages, limitations, and domain-specific applicability. We also highlight key innovations, ongoing challenges, and future directions. Furthermore, this review provides practical guidance to assist researchers in model selection and support developers in the design of novel AI tools. An online companion supplement providing an in-depth look at all methods discussed: https://zhanglab-kiz.github.io/review-ai-transcriptomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.